Back

Which patients benefit from Cardiac Resynchronization Therapy (CRT) ?

27 May 2018 (12:50 - 13:02)
Organised by:
Congress Presentation Part of: State of the art in device therapy for heart failure Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Kenneth Dickstein

Stavanger University Hospital, Stavanger (Norway)

6 More presentations in this session

Presentation thumbnail
Introduction - State of the art in device therapy for heart failure.
Professor C. Linde (Stockholm, SE)
Presentation thumbnail
Innovative technologies to increase response.
Doctor A. Patwala (Stoke-on-Trent, GB)
Presentation thumbnail
Follow-up of CRT patients and heart failure diagnostics.
Doctor A. Zaidi (Manchester, GB)
Presentation thumbnail
Which patients benefit from left ventricular assist devices?
Doctor M. Eissmann (Essen, DE)
Presentation thumbnail
Follow-up of left ventricular assist devices.
Mr T. Schloeglhofer (Vienna, AT)

Access the full session

Session thumbnail
State of the art in device therapy for heart failure

The Event

Event poster

Heart Failure 2018

27 May 2018 12:50 CET
You may be interested in
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023
thumbnail
Congress Presentation
Response to cardiac resynchronization therapy: is there one good criteria?
29 June 2021
thumbnail
Congress Presentation
Cardiac resynchronization therapy practice who gets it and why? A comparison between ESC HF registry, CRT Survey II and SwedeHF.
23 May 2022
thumbnail
Congress Session
Late-Breaking Science: cardiac implantable electrical devices
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources